← Open Payments lookup

SALIL KATHPALIA: Open Payments

NPI 1295875714 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$882 in 40 payments from 10 companies in 2025. Trend: 2023 $603 · 2024 $1,189 · 2025 $882

Food & beverage: $882
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$238
Axsome Therapeutics, Inc.5$200
Neurocrine BioSciences, Inc.4$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$89
ABBVIE INC.4$81
Alkermes, Inc.3$61
E.R. Squibb & Sons, L.L.C.3$61
Lundbeck LLC1$20
Takeda Pharmaceuticals U.S.A., Inc.1$18
Otsuka America Pharmaceutical, Inc.1$18

Products named: AUSTEDO XR, Auvelity, INGREZZA, CAPLYTA, VRAYLAR, ARISTADA, COBENFY, REXULTI.

Industry payments across NY — which companies pay providers there.